ArticleHealth & social care in the community2020
"Everyone needs to understand each other's systems": Stakeholder views on the acceptability and viability of a Pharmacist Independent Prescriber role in care homes for older people in the UK.
Article in Health & social care in the community, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 3 syntheses or guidelines pooled it, 31 citations in OpenAlex.
- Healthcare professionals' perspectives of pharmacist roles in residential aged care: a qualitative systematic review and meta-synthesis.International journal of clinical pharmacy · 2026Pooled it
- Pooled it
- Pooled it
- What happens when pharmacist independent prescribers lead on medicine management in older people's care homes: a qualitative study.BMJ open · 2023Trial
- Evaluation of effectiveness and safety of pharmacist independent prescribers in care homes: cluster randomised controlled trial.BMJ (Clinical research ed.) · 2023Trial
- Evaluation of a training programme for Pharmacist Independent Prescribers in a care home medicine management intervention.BMC medical education · 2022Trial
- Process evaluation for the Care Homes Independent Pharmacist Prescriber Study (CHIPPS).BMC health services research · 2021Trial
- Codesigning a pharmacist-led transition of care program in the emergency department: a qualitative participatory study.International journal of clinical pharmacy · 2026Article
- Developing a Pharmacist-Centered Novel Antimicrobial Stewardship (AMS) Approach for Healthcare in Pakistan: A Grounded Theory Study.Antibiotics (Basel, Switzerland) · 2025Article
- Article
- Service delivery and the role of clinical pharmacists in UK primary care for older people, including people with dementia: a scoping review.BMC primary care · 2025Article
- Evaluation of self-efficacy in Spanish nurse prescribers: are they qualified to safely and effectively prescribe medication and health devices?Frontiers in medicine · 2025Article
- Implementation of Nurse Prescriptions throughout the Public Health System in Catalonia (2021-2022).Healthcare (Basel, Switzerland) · 2024Article
- "Everyone needs to understand each other's systems": Stakeholder views on the acceptability and viability of a Pharmacist Independent Prescriber role in care homes for older people in the UK.Health & social care in the community · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 5 institutions in 1 country.
Funding
Abstract
The role of an innovative Pharmacist Independent Prescriber (PIP) for care homes to optimise medications has not been examined. We explored stakeholders' views on issues and barriers that the PIP might address to inform a service specification for the PIP intervention in older people's care homes. Focus groups (n = 72 participants) and semi-structured interviews (n = 13) undertaken in 2015 across four sites in the United Kingdom captured the views of doctors, pharmacists, care-home managers and staff, residents and relatives. Stakeholders identified their expectations of what service should be provided by PIPs, what might affect their support for the role, and barriers and enablers to providing the service. Transcripts were analysed using the Theoretical Domains Framework to identify key components, which were reviewed by stakeholders in 2016. A PIP service was envisaged offering benefits for residents, care homes and doctors but stakeholders raised challenges including agreement on areas where PIPs might prescribe, contextual barriers in chronic disease management, PIPs' knowledge of older people's medicine, and implementation barriers in integrated team-working and ensuring role clarity. Introducing a PIP was welcomed in principle but conditional on: a clearly defined PIP role communicated to stakeholders; collaboration across doctors, PIPs and care-home staff; dialogue about developing the service with residents and relatives, based on trust and effective communication. To embed a PIP service within increasingly complex care-homes provision, the overarching theme from this research was that everyone must "understand each other's systems".
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.